Category: Pharmacology

The class is pharmacology, within a nursing program. The case study requires 2 sources for each question. Overall 4 total references. APA 7th edition formatting. The prompts for the case study are located in the doc below.

Unit 11 Drug Reference Guide: Sleep Introduction Sleep disorders are common across clinical practice, and understanding the medications used to treat them is essential for safe and effective patient care. This assignment will guide you in exploring the primary drug classes prescribed for insomnia and other sleep-related conditions. Instructions Follow the instructions below to complete this assignment: Download the Template: Drug Reference Chart Template Download Drug Reference Chart Template[Word] Complete all required information listed in the chart for the medications provided below: Non-benzodiazepines: Suvorexant (Belsomra), Doxepin (Silenor), Zolpidem (Ambien), Zaleplon (Sonata), Eszopiclone (Lunesta). Melantonergic agents: Ramelteon Wake-promoting agents: Modafinil and Solriamfetol Off label Antidepressants used for insomnia: trazodone, mirtazapine Ensure you reference Stahls Essential Psychopharmacology Prescribers Guide for accuracy and completeness. Please review the provided rubric prior to submission to confirm that all criteria are met. Assignment Resources Use the following resource to help with this assignment (optional): Drug Reference Chart Template Download Drug Reference Chart Template[Word] Submit Submission Format Use the Drug Reference Chart Template and keep the assignment in a Word format Please review the provided rubric prior to submission to confirm that all criteria are met Due Sunday by 11:59 p.m. CT Estimated time to complete: 3 hours Rubric NU670: Unit 11 Assignment – Drug Reference Guide NU670: Unit 11 Assignment – Drug Reference Guide Criteria Ratings Pts This criterion is linked to a Learning OutcomeMedication Selection 2 pts Exemplary Accurately completes medications assigned by faculty; demonstrates clear understanding of each medications purpose and relevance to PMHNP practice. 1 pts Proficient Completes most assigned medications with generally accurate information; minor omissions noted. 0.5 pts Needs Improvement Missing several assigned medications or lacks clarity and completeness. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeFDA Indications 2 pts Exemplary Clearly and accurately lists FDA-approved indications using proper terminology; includes age/population specifics when applicable. 1 pts Proficient Includes most FDA indications but lacks specificity or omits minor details. 0.5 pts Needs Improvement Indications incomplete, unclear, or inaccurate. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeMechanism of Action 2 pts Exemplary Provides clear, concise, and accurate explanation demonstrating advanced understanding of pharmacodynamics and neurotransmitter activity. 1 pts Proficient Adequate explanation with minor gaps in accuracy or clarity. 0.5 pts Needs Improvement Limited or incorrect explanation of mechanism. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeSide & Adverse Effects 2 pts Exemplary Comprehensive and clinically prioritized list; identifies major risks and black box warnings where relevant. 1 pts Proficient Includes most effects with reasonable accuracy. 0.5 pts Needs Improvement Incomplete or inaccurate listing of effects. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeRequired Tests / Labs 2 pts Exemplary Accurately identifies baseline and ongoing lab requirements with rationale for monitoring. 1 pts Proficient Includes key labs but lacks rationale or detail. 0.5 pts Needs Improvement Missing or incorrect lab information. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomePrecautions & Contraindications 2 pts Exemplary Accurately lists major contraindications, precautions, and drug interactions; includes relevant population considerations. 1 pts Proficient Addresses most precautions and contraindications with minor omissions. 0.5 pts Needs Improvement Incomplete or inaccurate information. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeDosage Range / Dosage 2 pts Exemplary Provides accurate dosage ranges, available dosage forms (tablet, capsule, liquid, IM, etc.), and routes of administration; includes titration or adjustment parameters where applicable. 1 pts Proficient Includes general dosing information or partial list of dosage forms with minor gaps. 0.5 pts Needs Improvement Incomplete, inaccurate, or missing dosage details. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeAccuracy & Use of Evidence 2 pts Exemplary All information is accurate, current, and evidence-based using Stahls Essential Psychopharmacology/Prescribers Guide or other scholarly psychopharmacology sources. 1 pts Proficient Mostly accurate with minor unsupported details. 0.5 pts Needs Improvement Contains multiple inaccuracies or lacks credible evidence. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeOrganization & Professionalism 2 pts Exemplary Clear, well-organized, grammatically correct, and professionally formatted; easy to follow and visually clean. 1 pts Proficient Mostly organized and clear with few grammar or formatting errors. 0.5 pts Needs Improvement Disorganized, unclear, or unprofessional in presentation. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeCompleteness & Submission Quality 2 pts Exemplary All sections of the template are completed thoroughly and thoughtfully; demonstrates attention to detail. 1 pts Proficient Most sections complete but lacking in depth or thoroughness. 0.5 pts Needs Improvement Several sections incomplete or missing required information. 0 pts Absent No Submission 2 pts Total Points: 20

Unit 10 Drug Reference Guide: OCD Introduction ObsessiveCompulsive Disorder (OCD) is a chronic psychiatric condition characterized by intrusive thoughts and compulsive behaviors that significantly impair daily functioning. Pharmacologic management is a key component of treatment, often requiring careful selection and monitoring of medications based on evidence-based guidelines. This assignment focuses on developing a comprehensive drug reference chart for commonly used and adjunctive medications in OCD treatment. Using the provided template, you will document essential prescribing information for the primary antidepressants indicated for OCDParoxetine, Clomipramine, and Fluvoxamineas well as off-label options such as Memantine for augmentation and Topiramate for impulsivity. Instructions Follow the instructions below to complete this assignment: Download the Template: Drug Reference Chart Template Download Drug Reference Chart Template[Word] Complete all required information listed in the chart for the medications provided below: OCD Antidepressants: (Paroxetine, Clomipramine, Fluvoxamine) Off Label adjunctive: Memantine Off Label Impulsivity: Topiramate Ensure you reference Stahls Essential Psychopharmacology Prescribers Guide for accuracy and completeness. Please review the provided rubric prior to submission to confirm that all criteria are met. Assignment Resources Use the following resource to help with this assignment (optional): Drug Reference Chart Template Download Drug Reference Chart Template[Word] Submit Submission Format Use the Drug Reference Chart Template and keep the assignment in a Word format Please review the provided rubric prior to submission to confirm that all criteria are met Due Sunday by 11:59 p.m. CT Estimated time to complete: 3 hours Rubric NU670: Unit 10 Assignment – Drug Reference Guide NU670: Unit 10 Assignment – Drug Reference Guide Criteria Ratings Pts This criterion is linked to a Learning OutcomeMedication Selection 2 pts Exemplary Accurately completes medications assigned by faculty; demonstrates clear understanding of each medications purpose and relevance to PMHNP practice. 1 pts Proficient Completes most assigned medications with generally accurate information; minor omissions noted. 0.5 pts Needs Improvement Missing several assigned medications or lacks clarity and completeness. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeFDA Indications 2 pts Exemplary Clearly and accurately lists FDA-approved indications using proper terminology; includes age/population specifics when applicable. 1 pts Proficient Includes most FDA indications but lacks specificity or omits minor details. 0.5 pts Needs Improvement Indications incomplete, unclear, or inaccurate. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeMechanism of Action 2 pts Exemplary Provides clear, concise, and accurate explanation demonstrating advanced understanding of pharmacodynamics and neurotransmitter activity. 1 pts Proficient Adequate explanation with minor gaps in accuracy or clarity. 0.5 pts Needs Improvement Limited or incorrect explanation of mechanism. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeSide & Adverse Effects 2 pts Exemplary Comprehensive and clinically prioritized list; identifies major risks and black box warnings where relevant. 1 pts Proficient Includes most effects with reasonable accuracy. 0.5 pts Needs Improvement Incomplete or inaccurate listing of effects. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeRequired Tests / Labs 2 pts Exemplary Accurately identifies baseline and ongoing lab requirements with rationale for monitoring. 1 pts Proficient Includes key labs but lacks rationale or detail. 0.5 pts Needs Improvement Missing or incorrect lab information. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomePrecautions & Contraindications 2 pts Exemplary Accurately lists major contraindications, precautions, and drug interactions; includes relevant population considerations. 1 pts Proficient Addresses most precautions and contraindications with minor omissions. 0.5 pts Needs Improvement Incomplete or inaccurate information. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeDosage Range / Dosage 2 pts Exemplary Provides accurate dosage ranges, available dosage forms (tablet, capsule, liquid, IM, etc.), and routes of administration; includes titration or adjustment parameters where applicable. 1 pts Proficient Includes general dosing information or partial list of dosage forms with minor gaps. 0.5 pts Needs Improvement Incomplete, inaccurate, or missing dosage details. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeAccuracy & Use of Evidence 2 pts Exemplary All information is accurate, current, and evidence-based using Stahls Essential Psychopharmacology/Prescribers Guide or other scholarly psychopharmacology sources. 1 pts Proficient Mostly accurate with minor unsupported details. 0.5 pts Needs Improvement Contains multiple inaccuracies or lacks credible evidence. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeOrganization & Professionalism 2 pts Exemplary Clear, well-organized, grammatically correct, and professionally formatted; easy to follow and visually clean. 1 pts Proficient Mostly organized and clear with few grammar or formatting errors. 0.5 pts Needs Improvement Disorganized, unclear, or unprofessional in presentation. 0 pts Absent No Submission 2 pts This criterion is linked to a Learning OutcomeCompleteness & Submission Quality 2 pts Exemplary All sections of the template are completed thoroughly and thoughtfully; demonstrates attention to detail. 1 pts Proficient Most sections complete but lacking in depth or thoroughness. 0.5 pts Needs Improvement Several sections incomplete or missing required information. 0 pts Absent No Submission 2 pts Total Points: 20

Write 1500 words on Drug poster presentation

my assignment is on anxiety disorders in the BJCP report writting style. I have uploaded the brief and the template. I dont want Ai writing as I always receive non sense AI work even if the detection is 0%.